Roche Holding AG (LTS:0TDF) Other Operating Expense: $-343 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0TDF Roche Holding AG LTS:0TDF
78 GF Score
Price $50.35
GF Value $41.72
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG Other Operating Expense?

Roche Holding AG LTS:0TDF -0.92% 78 Other Operating Expense is $-343 Mil as of Dec. 2025. GuruFocus rates LTS:0TDF with a GF Score™ of 78/100 and a GF Value™ of $41.72 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Roche Holding AG's Other Operating Expense for the six months ended in Dec. 2025 was $-46 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $-343 Mil.

Roche Holding AG's quarterly Other Operating Expense declined from Dec. 2024 ($3,275 Mil) to Jun. 2025 ($-296 Mil) but then increased from Jun. 2025 ($-296 Mil) to Dec. 2025 ($-46 Mil).

Roche Holding AG's annual Other Operating Expense increased from Dec. 2023 ($-453 Mil) to Dec. 2024 ($2,798 Mil) but then declined from Dec. 2024 ($2,798 Mil) to Dec. 2025 ($-349 Mil).

Roche Holding AG Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Roche Holding AG's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG Other Operating Expense Chart

Roche Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,310.53 -885.57 -453.28 2,798.34 -348.85

Roche Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 526.13 -475.50 3,275.01 -296.36 -46.43
LTS:0TDF
78GF Score
Roche Holding AG LTS:0TDF
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roche Holding AG Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-343 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $-343 Mil mean?
Roche Holding AG (LTS:0TDF) has a Other Operating Expense of $-343 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Roche Holding AG and its competitors.
Is Roche Holding AG's Other Operating Expense too high?
Roche Holding AG's current Other Operating Expense is $-343 Mil. Overall, Roche Holding AG has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's Other Operating Expense compare to LLY and JNJ?
Roche Holding AG's Other Operating Expense of $-343 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Roche Holding AG and its competitors. Roche Holding AG's current Other Operating Expense is $-343 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (LTS:0TDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $41.72, compared to a current price of $50.35 — trading 20.7% above its estimated fair value. The current Other Operating Expense is $-343 Mil. Roche Holding AG's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Roche Holding AG (LTS:0TDF), the current Other Operating Expense is $-343 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Roche Holding AG (LTS:0TDF) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of $50.35 is trading 20.7% above its estimated GF Value™ of $41.72. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for LTS:0TDF:

  • Other Operating Expense: $-343 Mil
  • GF Value™: $41.72 vs. price of $50.35 (20.7% above fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the LTS:0TDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
78GF Score

Get the complete analysis for LTS:0TDF

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$50.35
Price
$41.72
GF Value